As part of the Inclusive Cancer Care Research Equity (iCCaRE) for Black Men Consortium, Mr Arnold Merriweather (Prostate Cancer Survivor and Community Advocate, MPI, Florida, USA), Dr Che Ngufor (MPI, Mayo Clinic, Rochester, USA) and Dr Folakemi Odedina (MPI, Mayo Clinic, Florida, USA) introduce us to the consortium and discuss why it was setup, its aims and objectives and its potential impact in local and global communities.

A key strategy of the iCCaRE for Black Men Consortium is to address the disproportionate burden of prostate cancer seen in African American men via increased access to life-changing, scientific prostate cancer discoveries, especially those with implications for primary and secondary preventive interventions as well as information that will enhance access to prostate cancer clinical trials.

Here the panel discuss: